This inventor holds 6 USPTO granted patents and 1 EPO patent. Top assignee: Sanofi. Active years: 2015-2021.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2015-2021
Title: Fabienne Chatreaux: Innovator in Thienopyrimidine Derivatives
Introduction
Fabienne Chatreaux is a prominent inventor based in Paris, France. She has made significant contributions to the field of medicinal chemistry, particularly in the development of thienopyrimidine derivatives. With a total of 6 patents to her name, her work has implications for therapeutic applications.
Latest Patents
Her latest patents focus on thienopyrimidine derivatives, detailing processes for their preparation and therapeutic uses. The inventions relate to compounds of specific formulas, where R6 can be a —CONH or a —C(R)(R)(OH) group. Additionally, R is described as a substituted phenyl or heteroaryl group, while R7 is an optionally substituted aryl or heteroaryl group. These innovations are crucial for advancing therapeutic options in various medical fields.
Career Highlights
Fabienne Chatreaux is currently employed at Sanofi, a leading global healthcare company. Her role involves extensive research and development in the pharmaceutical sector, where she applies her expertise in chemistry to create innovative solutions.
Collaborations
Throughout her career, she has collaborated with notable colleagues, including Jean-Christophe Carry and Stephanie Deprets. These partnerships have fostered a collaborative environment that enhances the innovation process.
Conclusion
Fabienne Chatreaux stands out as a key figure in the field of medicinal chemistry, with her innovative work on thienopyrimidine derivatives paving the way for future therapeutic advancements. Her contributions continue to impact the pharmaceutical industry positively.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
